Editing Organisation involving high tech, life sciences and biotech

Austrianova is one firm that does services that involves high tech, life sciences and biotech. It is complemented with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated company that specialises in the indusion of living cells or bacteria in tiny pills for shield which is also recognized as cell encapsulation technology, isolation, storage and transportation. We were first built in the year 2007 and was recognised in Singapore's top research biotech hub, Biopolis that has international vision in providing encapsulation choices like micro encapsulation. 

There is a speedy advancing matter of liking in healthy maintenance and more exact, in the topic of neutraceuticals which is the knowing and use of probiotic bacteria. So, probiotics encapsulation was formed. The cell-in-a-box technology was formed by Austranova with the target to guard, detach, collect and transport living cells. This protective finding can be used for several objectives and can be applied to probiotics, cosmetics and agriculture environmental protection and monitoring as well as creating the foundation of a controlling exploration device. 

In healthcare, this skill helps facilitates harmless implantation of cells or stem cells such as cell therapy, holding them alone from the immune system and permitting long stage construction of therapeutic molecules in patients. In biotechnology, the cell-in-a-box technology shields cells in bioreactors and fermentors and at the same time, it shorten sanitization of bioproducts formed from the cells and it reduces making price too.

A large ruler cGMP facility for the making of biomedical grade encapsulated cell products was used to positively created and right now, Austrianova is in the journey of setting up this experience in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow lesser doses of chemotherapy to be used more effectually without the casual enervating side consequences. The encapsulated cell are placed, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally alter a chemotherapeutic product to its tumor toxic product. 

Visit our web for more information: <strong><b>[http://austrianova.com/ Stem Cells]</b></strong>, <strong><b>[http://austrianova.com/ Capsules]</b></strong>, <strong><b>[http://austrianova.com/ Encapsulation Technology]</b></strong>.